Adial pharmaceuticals, inc. (ADIL)
CashFlow / Quarterly
Mar'20Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Loss

-2,276

-1,715

-2,134

-2,682

-1,269

-8,190

-1,792

-378

Adjustments to reconcile net loss to net cash used in operating activities:
Equity-based compensation

570

384

464

284

299

3,468

1,531

69

Non-cash warrant modification expense

-

0

0

441

-

-

-

-

Amortization of intangible assets

0

0

0

0

0

0

0

0

Amortization of debt discounts

-

-

-

-

186

105

28

32

Loss on debt extinguishments

-

-

-

-

0

-3,496

0

12

Changes in operating assets and liabilities:
Prepaid research and development expenses

206

188

-107

-126

-

-

-

-

Prepaid expenses and other current assets

-119

355

-124

-38

-

-

-

-

Accounts payable

-

-

-

-

-112

-217

64

75

Accrued expenses

-38

-

-

110

-

-

-

-

Accounts payable

6

-

-

-39

-

-

-

-

Net cash used in operating activities

-1,825

-1,724

-1,140

-1,721

-1,103

-991

-188

-214

CASH FLOWS FROM FINANCING ACTIVITIES:
Net proceeds from sale of common stock and warrants

-

0

0

8,195

-

-

-

-

Proceeds from Senior Secured Notes, including related party

-

-

-

-

0

0

9

400

Repayment of Senior Secured Bridge Note

-

-

-

-

0

0

0

150

Proceeds from warrant exercise

-

0

0

1,050

-

-

-

-

Net cash provided by financing activities

-

0

0

9,246

156

5,657

284

250

NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS

-1,825

-1,724

-1,140

7,525

-947

4,666

96

35

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Previously accrued expenses paid in equity

117

-

-

-

-

-

-

-

NON-CASH INVESTING AND FINANCING ACTIVITIES:
Senior note issued for payment to Senior Bridge Note

-

-

-

-

-

-

-

150

Senior note issued for Subscription Receivable

-

-

-

-

-

-

-

10

Exchange of Subordinated notes in the amount of $115,639 for Senior secured notes

-

-

-

-

0

0

0

100